A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Clinical trial NCT06515613 · RECRUITING

Trial details

NCT number: NCT06515613
Sponsor: Context Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Testicular Cancer Endometrial Cancer

Start date: 2024-07-10
Primary completion: 2028-05-31
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.